01 22care4 ApS
02 2AbZ-Pharma GmbH
03 12Accord healthcare
04 25Amgen Inc
05 2Apotex Fermentation Inc.
06 2Apotex Inc
07 4Hangzhou Jiuyuan Gene Engineering
08 2Hexal AG
09 13Hospira, Inc.
10 4Kashiv BioSciences
11 1Landsteiner
12 3Northern Medical Group ApS
13 4ORIFARM GROUP AS
14 6Pfizer Consumer Healthcare
15 4Pfizer Inc
16 2Pooyesh Darou Biopharmaceutical Co.
17 4Ratiopharm GmbH
18 17Sandoz B2B
19 1Siam Bioscience
20 2TANVEX BIOPHARMA USA, INC.
21 12Teva Pharmaceutical Industries
22 1UAB "Sicor Biotech"
23 1UAB SICOR BIOTECH
01 1Filgrastim 12,000.000Iu 0.2Ml 1 Unit Parenteral Use
02 6Filgrastim 30,000.000Iu 1 Unit Parenteral Use
03 1Filgrastim 30,000.000Iu 5 Units Parenteral Use
04 2Filgrastim 48,000.000Iu 1 Unit Parenteral Use
05 7INJ
06 4INJECTABLE;INJECTION
07 6INJECTION / CONCENTRATE FOR
08 7INJECTION / INFUSION
09 3Inj L?s
10 2Inj Loose
11 4Inj Sol
12 2Inj Solution
13 1Inj. Soluble
14 2Inj. Solution
15 6Injection
16 3Injection fluid, resolution
17 4Injection fluid, resolution/concentrate to the infusion fluid
18 10Injection/infusion fluid, resolution
19 1Lipegfilgrastim 6Mg 1 Unit Parenteral Use
20 5PFS
21 1Pegfilgrastim 6Mg 1 Unit Parenteral Use
22 11SOLUTION
23 1SOLUTION FOR INJECTION
24 14SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
25 2SOLUTION;INTRAVENOUS, SUBCUTANEOUS
26 2SOLUTION;SUBCUTANEOUS
27 2SYRINGE
28 1Solution For Injection
29 1Tablet
30 2VIAL
31 2VIAL;SINGLE-DOSE
32 10injection
01 11Generic
02 3Originator
03 11Prescription
04 101Blank
01 8Accofil
02 1Biofilgran
03 2Biograstim
04 1FILGRASTIM TEVA 30
05 1FILGRASTIM TEVA 48
06 4Filgrastim-Teva
07 2GRASTOFIL
08 1Granulokine
09 1Granulokine
10 1Grastiva 300
11 1Grastiva 480
12 2Grastofil
13 4JILIFEN
14 1Leuco-Plus
15 2Lonquex
16 8NEUPOGEN
17 8NIVESTYM
18 2NYPOZI
19 1Neukast 300
20 1Neukast 480
21 3Neulasta
22 4Neupogen
23 1Neupogen 30
24 1Neupogen 30 Mu
25 1Neupogen 48 Mu
26 3Neupogen Amgen
27 10Neupogen Novum
28 3Nivest
29 12Nivestim
30 1PDgrastim
31 1PDlasta
32 4RELEUKO
33 4Ratiograstim
34 2Tagrast
35 5Tevagrastim
36 2ZARXIO
37 12Zarzio
38 2Zarzio 30 MU
39 1Zarzio 48 MU
40 2filgrastim Hexal
01 10Australia
02 11Canada
03 4China
04 2Iran
05 12Italy
06 1Mexico
07 17Norway
08 12South Africa
09 28Sweden
10 14Switzerland
11 1Thailand
12 14USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Accofil
Dosage Form : INJECTION / INFUSION
Dosage Strength : 48 MU / 0.5 ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Accofil
Dosage Form : INJECTION / INFUSION
Dosage Strength : 30 MU / 0.5 ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : USA
Brand Name : NEUPOGEN
Dosage Form : VIAL
Dosage Strength : 300MCG/1ML
Packaging :
Approval Date :
Application Number : 103353
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NEUPOGEN
Dosage Form : VIAL
Dosage Strength : 480MCG/1.6ML
Packaging :
Approval Date :
Application Number : 103353
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NEUPOGEN
Dosage Form : SYRINGE
Dosage Strength : 300MGC/0.5ML
Packaging :
Approval Date :
Application Number : 103353
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NEUPOGEN
Dosage Form : SYRINGE
Dosage Strength : 480MCG/0.8ML
Packaging :
Approval Date :
Application Number : 103353
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : filgrastim Hexal
Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
Dosage Strength : 30 MU / 0.5 ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : filgrastim Hexal
Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
Dosage Strength : 48 MU / 0.5 ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : USA
Brand Name : NIVESTYM
Dosage Form : VIAL;SINGLE-DOSE
Dosage Strength : 300MCG/ML
Packaging :
Approval Date :
Application Number : 761080
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NIVESTYM
Dosage Form : VIAL;SINGLE-DOSE
Dosage Strength : 480MCG/1.6ML
Packaging :
Approval Date :
Application Number : 761080
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NIVESTYM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 300MCG/0.5ML
Packaging :
Approval Date :
Application Number : 761080
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NIVESTYM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 480MCG/0.8ML
Packaging :
Approval Date :
Application Number : 761080
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RELEUKO
Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 300MCG/ML/VIAL
Packaging :
Approval Date :
Application Number : 761082
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RELEUKO
Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 480MCG/1.6ML/VIAL
Packaging :
Approval Date :
Application Number : 761082
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RELEUKO
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 300MCG/0.5ML
Packaging :
Approval Date :
Application Number : 761082
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RELEUKO
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 480MCG/0.8ML
Packaging :
Approval Date :
Application Number : 761082
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ZARXIO
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 300 mcg/0.5 mL
Packaging :
Approval Date :
Application Number : 125553
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ZARXIO
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 480 mcg/0.8 mL
Packaging :
Approval Date :
Application Number : 125553
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Biograstim
Dosage Form : INJECTION / CONCENTRATE FOR
Dosage Strength : 48 MIU
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Sweden
Brand Name : Biograstim
Dosage Form : INJECTION / CONCENTRATE FOR
Dosage Strength : 30 MIU
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
